Abluminus Sirolimus DES+ vs. Everolimus-Eluting Stents in Patients with Diabetes Mellitus: Final 2-Year Results of the ABILITY Global Study
We Recommend
Disclosures
<p>Nothing to disclose</p>
New at TCTMD? Register today!
Enter the email you used to register to reset your password.